StockNews.com Downgrades Acadia Healthcare (NASDAQ:ACHC) to Sell

Acadia Healthcare (NASDAQ:ACHC) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Friday.

Other research analysts have also recently issued reports about the stock. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. KeyCorp began coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upped their price target on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays decreased their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $79.67.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $38.23 on Friday. The stock has a 50 day moving average of $54.15 and a 200 day moving average of $64.55. The company has a market capitalization of $3.55 billion, a price-to-earnings ratio of 12.53, a PEG ratio of 1.71 and a beta of 1.33. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same period last year, the firm posted $0.91 EPS. As a group, sell-side analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares in the last quarter. Commonwealth Equity Services LLC boosted its position in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares during the last quarter. Atria Investments Inc grew its holdings in shares of Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after purchasing an additional 308 shares in the last quarter. Finally, KBC Group NV increased its position in shares of Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after purchasing an additional 338 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.